These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 12430363)

  • 81. Medicare reform and social insurance: the clashes of 2003 and their potential fallout.
    Marmor TR; Hacker JS
    Yale J Health Policy Law Ethics; 2005; 5(1):475-89. PubMed ID: 15742590
    [No Abstract]   [Full Text] [Related]  

  • 82. Congressional healthcare outlook: prescription drugs.
    Graham SB
    Hosp Outlook; 2001 Jul; 4(5):6, 12. PubMed ID: 11478182
    [No Abstract]   [Full Text] [Related]  

  • 83. A line in the sand: the politics of Medicare reform.
    Scott JS
    Healthc Financ Manage; 2003 Jun; 57(6):24-5. PubMed ID: 12866422
    [No Abstract]   [Full Text] [Related]  

  • 84. More bills coming due. Although Medicare reform has passed Congress, the final package remains uncertain. And what about the fate of other health legislation?
    Fong T; Tieman J
    Mod Healthc; 2003 Jul; 33(27):28-31. PubMed ID: 12884728
    [No Abstract]   [Full Text] [Related]  

  • 85. Massachusetts' Proposed Medicaid Reforms - Cheaper Drugs and Better Coverage?
    Sommers BD; Kesselheim AS
    N Engl J Med; 2018 Jan; 378(2):109-111. PubMed ID: 29236573
    [No Abstract]   [Full Text] [Related]  

  • 86. Prescription drug access: the ANA adopts principles to evaluate congressional Medicare proposals.
    McKeon E
    Am J Nurs; 2003 Sep; 103(9):106. PubMed ID: 14501485
    [No Abstract]   [Full Text] [Related]  

  • 87. The game that won't end. Months after passage, drug benefit law remains a political football.
    Sloane T
    Mod Healthc; 2004 Mar; 34(10):30. PubMed ID: 15069932
    [No Abstract]   [Full Text] [Related]  

  • 88. SLC brings MA health care to KY.
    J Ky Med Assoc; 2006 Sep; 104(9):407-8. PubMed ID: 17100118
    [No Abstract]   [Full Text] [Related]  

  • 89. The Massachusetts model: an artful balance.
    Turnbull NC
    Health Aff (Millwood); 2006; 25(6):w453-6. PubMed ID: 16973649
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Value-Based Pricing and State Reform of Prescription Drug Costs.
    Hwang TJ; Kesselheim AS; Sarpatwari A
    JAMA; 2017 Aug; 318(7):609-610. PubMed ID: 28692713
    [No Abstract]   [Full Text] [Related]  

  • 91. The Medicare Part D drug benefit: lessons from the experience with drug discount cards.
    Doering PL
    Am J Geriatr Cardiol; 2005; 14(6):308-12. PubMed ID: 16276128
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Health care reform and the pharmaceutical industry.
    Mossinghoff GJ
    Health Care Manag; 1994 Aug; 1(1):187-96. PubMed ID: 10152353
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Medicare modernization and distributional implications.
    Swartz K
    Inquiry; 2003; 40(4):315-7. PubMed ID: 15055831
    [No Abstract]   [Full Text] [Related]  

  • 94. Medicare drug therapy in the elderly: pharmacotherapy, politics, and economics at the crossroads.
    Wenger NK; Weber MA; Scheidt S
    Am J Geriatr Cardiol; 2005; 14(6):282-3. PubMed ID: 16276123
    [No Abstract]   [Full Text] [Related]  

  • 95. On easy solutions.
    Lowe RA; Schull M
    Ann Emerg Med; 2011 Sep; 58(3):235-8. PubMed ID: 21546118
    [No Abstract]   [Full Text] [Related]  

  • 96. A political history of medicare and prescription drug coverage.
    Oliver TR; Lee PR; Lipton HL
    Milbank Q; 2004; 82(2):283-354. PubMed ID: 15225331
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Challenging pharmaceutical industry political power in Maine and Vermont.
    Castellblanch R
    J Health Polit Policy Law; 2003 Feb; 28(1):109-32. PubMed ID: 12705419
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Whither seniors' pharmacare: lessons from (and for) Canada.
    Morgan SG; Barer ML; Agnew JD
    Health Aff (Millwood); 2003; 22(3):49-59. PubMed ID: 12757272
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Incentives and pharmaceutical reimbursement reforms in Spain.
    Puig-Junoy J
    Health Policy; 2004 Feb; 67(2):149-65. PubMed ID: 14720633
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Drug benefit plans under managed care: to what extent do older subscribers selecting less drug coverage put themselves at increased financial risk?
    Andrade SE; Gurwitz JH
    J Am Geriatr Soc; 2002 Jan; 50(1):178-81. PubMed ID: 12028265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.